Income Statement
ZEVRA THERAPEUTICS, INC.
ZVRA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - | 0.00 |
|
Cost of Revenue
|
- | - | 2.95 | 0.34 | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | -2.95 | -0.34 | - | - | - | - | - | - | - |
|
Operating Expenses
|
77.62 | 54.87 | 34.31 | 15.34 | 18.86 | 16.76 | 30.23 | 55.90 | 33.37 | 37.48 | 22.81 |
|
Research & Development
|
12.74 | 42.10 | 39.81 | 19.61 | 10.16 | 8.84 | 19.42 | 41.76 | 20.59 | 20.47 | 13.93 |
|
Selling, General & Administrative
|
77.62 | 54.87 | 34.31 | 15.34 | 8.70 | 7.92 | 10.82 | 12.51 | 12.77 | 14.00 | 8.88 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-77.62 | -54.87 | -37.26 | -15.69 | -18.86 | -16.76 | -30.23 | -55.90 | -33.37 | -37.48 | -22.81 |
|
Non-Operating Income
|
149.62 | -3.14 | 3.56 | 0.18 | -16.25 | -7.19 | -4.21 | -0.69 | -10.06 | 20.95 | -31.82 |
|
Interest Income
|
7.57 | 3.16 | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | 1.50 | 0.34 | 0.23 | 4.79 | 4.86 | 5.47 | 5.78 | 5.51 | 2.67 |
|
Other Non-Op Income / Expense
|
-133.74 | 6.21 | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
86.68 | -90.14 | 26.80 | -42.30 | -8.50 | -12.79 | -24.54 | -56.59 | -43.43 | -16.53 | -54.64 |
|
Income Tax Expense
|
3.45 | 15.37 | 0.00 | -0.79 | -8.52 | -0.03 | -0.02 | -0.13 | -0.04 | -0.02 | 0.03 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
83.23 | -105.51 | -46.05 | -41.54 | 0.00 | 12.76 | 24.52 | 56.47 | -43.39 | -16.52 | -54.66 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-73.56 | -48.48 | -36.25 | -14.74 | -18.61 | -16.49 | -29.93 | -55.58 | -33.03 | -37.31 | -22.73 |
|
Earnings Per Share (Basic)
|
1.40 | -2.28 | -1.30 | -1.20 | -2.11 | - | - | - | - | - | - |
|
Diluted EPS
|
1.35 | - | - | - | -2.11 | - | - | - | - | - | - |
|
Weighted Average Shares
|
55.31 | 46.25 | 35.45 | 34.49 | 29.77 | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
57.26 | - | - | - | 29.77 | - | - | - | - | - | - |
|
Comprehensive Income
|
81.83 | -104.84 | -46.21 | -41.43 | - | - | - | - | - | - | - |